Bharat Biotech signs Covid19 vaccine deal with Brazil
Bharat Biotech International Limited on Friday announced that the company has signed an agreement with Brazil for supply of 20 million doses of its covid-19 vaccine COVAXIN. “The company has signed an agreement for delivery of COVAXIN®️ during Q2 and Q3 2021. The company is delighted to partner with Brazil in its battle against Covid-19 and aid its immunization program against the virus,” Bharat Biotech said in a statement.
There is a strong interest in Covaxin from many countries around the world, and the company is fully committed to ensuring supplies promptly and efficiently, the vaccine maker said in a statement. We will soon firm up the Covaxin delivery plan for the mass vaccination of our people, and further strengthen our partnership on intranasal vaccine supplies after initial results from its Phase 1 trials,” he had said.
Brazil President Jair Bolsonaro thanked Prime Minister Narendra Modi by saying “dhanyavaad” for supplying the “sanjeevni booti” (the vaccine) against the coronavirus to the South American country, which has reported the second-highest death toll from the Covid-19 disease in the world.
In January, India had dispatched 2 million doses of Covishield vaccines to Brazil. Covishield has been developed by Astrazeneca and Oxford University and is being manufactured by Serum Institute of India.